Advertisement

HNO

, Volume 63, Issue 7, pp 489–496 | Cite as

Stimmlippeninjektion zur Stimmverbesserung

Rückblick auf über 500 Operationen
  • M. TiggesEmail author
  • M. Hess
Leitthema

Zusammenfassung

Hintergrund

Heiserkeit, die auf einem unzureichenden Stimmlippenschluss beruht, kann durch Injektion von Füllsubstanzen in die betroffene Stimmlippe behandelt werden. Durch eine Verbesserung der zur Verfügung stehenden Injektionsmaterialien und Erschließung weiterer operativer Zugangswege hat sich das Spektrum der Behandlungsmöglichkeiten erweitert. Die Behandlung kann in Oberflächenanästhesie oder Narkose durchgeführt werden. Eine sorgfältige Indikationsstellung ist für den Behandlungserfolg ausschlaggebend.

Ziel

Es werden derzeit verwendete Injektionsmaterialien, operative Zugangswege und differenzialtherapeutische Möglichkeiten beschrieben.

Material und Methoden

Für die Übersicht wurde eine Literaturrecherche durchgeführt und Erfahrungen aus über 500 eigenen Stimmlippeninjektionen zusammengefasst.

Ergebnisse und Diskussion

Durch gezielten Einsatz der zur Verfügung stehenden Injektionsmaterialien kann eine befriedigende Stimmverbesserung bei geringer Patientenbelastung erreicht werden. Voraussetzung für den Behandlungserfolg ist die geeignete Indikationsstellung. Wünschenswert sind eine weitere Verbesserung der Injektionsmaterialien hinsichtlich gut einschätzbarer Verweildauer im Gewebe und eine Verbesserung der Biokompatibilität.

Schlüsselwörter

Stimmbandfunktionsstörung Stimmlippenaugmentation Stimmqualität Heiserkeit Ambulante Operationsverfahren 

Glottis injection to improve voice function

Review of more than 500 operations

Abstract

Background

Hoarseness due to insufficient glottal closure can be treated by injection laryngoplasty (augmentation). Vocal fold injections can be performed as an in-office procedure or under general anesthesia. As injection materials have recently improved and different injection approaches are available, injection laryngoplasties are performed much more frequently.

Objectives

Advantages and disadvantages of injection materials, laryngeal approaches, and differential indications are described.

Materials and methods

Literature research and experience of more than 500 laryngeal injection procedures are provided.

Results and conclusions

Sophisticated use of available injection materials can provide a satisfying improvement of voice function with minimal patient discomfort. Adequate indication is mandatory for a favorable outcome. Further improvement regarding biocompatibility and the duration of injection materials is desirable.

Keywords

Vocal cord dysfunction Vocal cord augmentation Voice quality Hoarseness Ambulatory surgical procedures 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

M. Tigges und M. Hess geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Amin MR (2006) Thyrohyoid approach for vocal fold augmentation. Ann Otol Rhinol Laryngol 115:699–702PubMedCrossRefGoogle Scholar
  2. 2.
    Anderson TD, Mirza N (2001) Immediate percutaneous medialization for acute vocal fold immobility with aspiration. Laryngoscope 111:1318–1321PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson TD, Sataloff RT (2004) Complications of collagen injection of the vocal fold: report of several unusual cases and review of the literature. J Voice 18:392–397PubMedCrossRefGoogle Scholar
  4. 4.
    Bové MJ, Jabbour N, Krishna P, Flaherty K, Saul M, Wunar R, Rosen CA (2007) Operating room versus office-based injection laryngoplasty: a comparative analysis of reimbursement. Laryngoscope 117:226–230PubMedCrossRefGoogle Scholar
  5. 5.
    Brandenburg JH, Kirkham W, Koschkee D (1992) Vocal cord augmentation with autogenous fat. Laryngoscope 102:495–500PubMedCrossRefGoogle Scholar
  6. 6.
    Bruenings W (1911) Über eine neue Behandlungsmethode der Rekurrenslähmung. Ver Deutsch Laryng 18:93–151Google Scholar
  7. 7.
    Cantarella G, Mazzola RF, Domenichini E, Arnone F, Maraschi B (2005) Vocal fold augmentation by autologous fat injection with lipostructure procedure. Otolaryngol Head Neck Surg 132:239–243PubMedCrossRefGoogle Scholar
  8. 8.
    Carroll TL, Rosen CA (2010) Trial vocal fold injection. J Voice 24:494–498PubMedCrossRefGoogle Scholar
  9. 9.
    Caton T, Thibeault SL, Klemuk S, Smith ME (2007) Viscoelasticity of hyaluronan and nonhyaluronan based vocal fold injectables: implications for mucosal versus muscle use. Laryngoscope 117:516–521PubMedCrossRefGoogle Scholar
  10. 10.
    Chen YY, Pai L, Lin YS, Wang HW, Hsiung MW (2003) Fat augmentation for nonparalytic glottic insufficiency. ORL J Otorhinolaryngol Relat Spec 65:176–183PubMedCrossRefGoogle Scholar
  11. 11.
    DeFatta RA, DeFatta RJ, Sataloff RT (2013) Laryngeal lipotransfer: review of a 14-year experience. J Voice 27:512–515PubMedCrossRefGoogle Scholar
  12. 12.
    Dursun G, Boynukalin S, Ozgursoy OB, Coruh I (2008) Long-term results of different treatment modalities for glottic insufficiency. Am J Otolaryngol 29:7–12PubMedCrossRefGoogle Scholar
  13. 13.
    Ford CN, Bless DM (1986) Clinical experience with injectable collagen for vocal fold augmentation. Laryngoscope 96:863–869PubMedCrossRefGoogle Scholar
  14. 14.
    Giraldez-Rodriguez LA, Johns M 3rd (2013) Glottal insufficiency with aspiration risk in dysphagia. Otolaryngol Clin North Am 46:1113–1121PubMedCrossRefGoogle Scholar
  15. 15.
    Halderman AA, Bryson PC, Benninger MS, Chota R (2014) Safety and length of benefit of restylane for office-based injection medialization – a retrospective review of one institution’s experience. J Voice 28:631–635PubMedCrossRefGoogle Scholar
  16. 16.
    Havas TE, Priestley KJ (2003) Autologous fat injection laryngoplasty for unilateral vocal fold paralysis. ANZ J Surg 73:938–943PubMedCrossRefGoogle Scholar
  17. 17.
    Hertegård S, Hallén L, Laurent C, Lindström E, Olofsson K, Testad P, Dahlqvist A (2004) Cross-linked hyaluronan versus collagen for injection treatment of glottal insufficiency: 2-year follow-up. Acta Otolaryngol 124:1208–1214PubMedCrossRefGoogle Scholar
  18. 18.
    Hsiung MW, Chen YY, Pai L, Lin CJ, Wang HW (2003) Results of magnetic resonance imaging assessment, acoustic analysis, phonatory function and perceptual rating of glottic insufficiency before and after fat augmentation: correlated with subjective rating. ORL J Otorhinolaryngol Relat Spec 65:76–83PubMedCrossRefGoogle Scholar
  19. 19.
    Hsiung MW, Lin YS, Su WF, Wang HW (2003) Autogenous fat injection for vocal fold atrophy. Eur Arch Otorhinolaryngol 260:469–474PubMedCrossRefGoogle Scholar
  20. 20.
    Jamal N, Mundi J, Chhetri DK (2014) Higher risk of superficial injection during injection laryngoplasty in women. Am J Otolaryngol 35:159–163PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Kasperbauer JL (1995) Injectable Teflon for vocal cord paralysis. Otolaryngol Clin North Am 28:317–323PubMedGoogle Scholar
  22. 22.
    Kwon TK, Rosen CA, Gartner-Schmidt J (2005) Preliminary results of a new temporary vocal fold injection material. J Voice 19:668–673PubMedCrossRefGoogle Scholar
  23. 23.
    Laccourreye O, Papon JF, Kania R, Crevier-Buchman L, Brasnu D, Hans S (2003) Intracordal injection of autologous fat in patients with unilateral laryngeal nerve paralysis: long-term results from the patient’s perspective. Laryngoscope 113:541–545PubMedCrossRefGoogle Scholar
  24. 24.
    Lakhani R, Fishman JM, Bleach N, Costello D, Birchall M (2012) Alternative injectable materials for vocal fold medialisation in unilateral vocal fold paralysis. Cochrane Database Syst Rev 17:CD009239Google Scholar
  25. 25.
    Mallur PS, Rosen CA (2013) Office-based laryngeal injections. Otolaryngol Clin North Am 46:85–100PubMedCrossRefGoogle Scholar
  26. 26.
    Mathison CC, Villari CR, Klein AM, Johns MM 3rd (2009) Comparison of outcomes and complications between awake and asleep injection laryngoplasty: a case-control study. Laryngoscope 119:1417–1423PubMedCrossRefGoogle Scholar
  27. 27.
    McCulloch TM, Andrews BT, Hoffman HT, Graham SM, Karnell MP, Minnick C (2002) Long-term follow-up of fat injection laryngoplasty for unilateral vocal cord paralysis. Laryngoscope 112:1235–1238PubMedCrossRefGoogle Scholar
  28. 28.
    Mikaelian DO, Lowry LD, Sataloff RT (1991) Lipoinjection for unilateral vocal cord paralysis. Laryngoscope 101:465–468PubMedCrossRefGoogle Scholar
  29. 29.
    Nakayama M, Ford CN, Bless DM (1993) Teflon vocal fold augmentation: failures and management in 28 cases. Otolaryngol Head Neck Surg 109:493–498PubMedGoogle Scholar
  30. 30.
    Ovari A, Witt G, Schuldt T, Hingst V, Pau HW, Jäckel M, Dommerich S (2014) Polydimethylsiloxane for injection laryngoplasty: two cases necessitating tracheotomy. Eur Arch Otorhinolaryngol 271:839–844PubMedCrossRefGoogle Scholar
  31. 31.
    Prendes BL, Yung KC, Likhterov I, Schneider SL, Al-Jurf SA, Courey MS (2012) Long-term effects of injection laryngoplasty with a temporary agent on voice quality and vocal fold position. Laryngoscope 122:2227–2233PubMedCrossRefGoogle Scholar
  32. 32.
    Remacle M, Lawson G, Delos M, Jamart J (1999) Correcting vocal fold immobility by autologous collagen injection for voice rehabilitation. A short-term study. Ann Otol Rhinol Laryngol 108:788–793PubMedCrossRefGoogle Scholar
  33. 33.
    Rihkanen H (1998) Vocal fold augmentation by injection of autologous fascia. Laryngoscope 108:51–54PubMedCrossRefGoogle Scholar
  34. 34.
    Schramm VL, May M, Lavorato AS (1978) Gelfoam paste injection for vocal cord paralysis: temporary rehabilitation of glottic incompetence. Laryngoscope 88:1268–1273PubMedGoogle Scholar
  35. 35.
    Sittel C, Echternach M, Federspil PA, Plinkert PK (2006) Polydimethylsiloxane particles for permanent injection laryngoplasty. Ann Otol Rhinol Laryngol 115:103–109PubMedCrossRefGoogle Scholar
  36. 36.
    Sittel C, Thumfart WF, Pototschnig C, Wittekindt C, Eckel HE (2000) Textured polydimethylsiloxane elastomers in the human larynx: safety and efficiency of use. J Biomed Mater Res 53:646–650PubMedCrossRefGoogle Scholar
  37. 37.
    Sulica L, Rosen CA, Postma GN, Simpson B, Amin M, Courey M, Merati A (2010) Current practice in injection augmentation of the vocal folds: indications, treatment principles, techniques, and complications. Laryngoscope 120:319–325PubMedGoogle Scholar
  38. 38.
    Ward PH, Hanson DG, Abemayor E (1985) Transcutaneous Teflon injection of the paralyzed vocal cord: a new technique. Laryngoscope 95:644–649PubMedCrossRefGoogle Scholar
  39. 39.
    Yung KC, Likhterov I, Courey MS (2011) Effect of temporary vocal fold injection medialization on the rate of permanent medialization laryngoplasty in unilateral vocal fold paralysis patients. Laryngoscope 121:2191–2194PubMedCrossRefGoogle Scholar
  40. 40.
    Zeitler DM, Amin MR (2007) The thyrohyoid approach to in-office injection augmentation of the vocal fold. Curr Opin Otolaryngol Head Neck Surg 15:412–416PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Städtisches Klinikum Karlsruhe gGmbHKarlsruheDeutschland
  2. 2.DEUTSCHE STIMMKLINIKHamburgDeutschland

Personalised recommendations